Merck to collaborate with Ontada on data-driven cancer insights

By Jenni Spinner

- Last updated on GMT

(FatCamera/iStock via Getty Images Plus)
(FatCamera/iStock via Getty Images Plus)

Related tags Merck millipore MSD Cancer Oncology RWE RWD

Merck (known as MSD outside the US and Canada) will partner with the data insights firm on solutions that progress real-world research and innovations.

Ontada, the oncology and insights business of McKesson, has announced a strategic partnership with Merck (MSD outside the US and Canada), geared toward the development of real-world research and solutions for cancer care. The agreement reportedly enables the two firms to use real-world evidence (RWE) to generate solutions that improve patient outcomes and the quality of oncological care.

Ontada president Susan Shiff said the company brings to the table a history of community oncology experience.

With data insights from greater than 2m records available for research and more than 2,000 oncology providers, Ontada helps life sciences companies like Merck leverage real-world data (RWD) and evidence-based insights at the point of care to accelerate innovation and improve cancer therapy​,” Shiff remarked.

Merck and Ontada reportedly plan to collaborate on RWD studies, with the intent of exploring new scientific evidence, developing advanced methods, and assessing of efficiency in cancer care. 

Merck is focused on bringing excellence to RWE generation by advancing methods and applying rigorous methods to gain RWD-based insights,​” said Ravinder Dhawan, vice president and head of the Center for Observational and Real-World Evidence (CORE) of Merck Research Laboratories. “We look forward to working with Ontada on our shared purpose of improving the lives of patients with cancer.​”

Marcus Neubauer, chief medical officer of the US Oncology Network, said when organizations like Merck and Ontada work together to come up with research and care solutions, patients reap the benefits.

RWD study results build on the body of evidence that oncology providers use for treatment decision making, which leads to improvements in patient outcomes,​” Neubauer commented.

Ontada works to combine RWD and research capabilities, targeted channels to connect life sciences and providers for education and engagement, technologies suited to oncology clinicians. The company’s offerings in this sphere include iKnowMed electronic health record system and Clear Value Plus regimen support. 

Related news

Show more

Related products

show more

Are You Prepared to Meet the New FDA Guidelines?

Are You Prepared to Meet the New FDA Guidelines?

Elligo Health Research® | 23-Mar-2023 | Insight Guide

On April 15, 2022, the U.S. Food and Drug Administration issued a new draft guidance to clinical research sponsors on creating a plan to enroll more participants...

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Formedix | 10-Mar-2023 | Technical / White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

4 Warning Signs Your Research Site Is in Trouble

4 Warning Signs Your Research Site Is in Trouble

Elligo Health Research® | 10-Mar-2023 | Insight Guide

You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article...

How Sponsors Reduce Chaos in Decentralized Trials

How Sponsors Reduce Chaos in Decentralized Trials

Florence Healthcare | 08-Mar-2023 | Insight Guide

89% of research sponsors currently use and expect to continue the use of decentralized technologies and methods, according to our state of the industry...

Related suppliers

Follow us


View more